RE:RE:I still expect a bounce .... .maybe back to $7.50KingTiger wrote: agree im buying back in when i see some research on Cresco there is a lack of info regarding there profitability.
There's no lack of information, only a lack of DD. Look through the Filing Statement on SEDAR, it's all there. Here's a quick & dirty breakdown w/o accounting for 'gain on biological assets' (which tends to distort all statements for cannabis companies) and rounded figures for simplicity:
Quarterlies (3 months ending June, 2018): - Cash: 31m
- Biological: 4.8m
- Inventory: 6.0m
- PP&E: 16.7m
- Total Assets: 74m (only 3.4m in intangible assets) - Revs: 8.5m
- COGS: 4.5m
- GP: 3.5m - Expenses: 2.6m (84% SG&A)
- Operating Profit: 0.9m - Other Expenses: 340k
- Net Income: 560k Anything 'income' on a net basis (per quarter) is golden in this sector. It's still early days in the US, and these guys are expanding very quickly (ops in 9 states and growing!) Solid C-Suite and branding is already on point... I think these guys will be winners.